CClinicalTrials.gg
SuspendedNCT05915234ECCRIOGASUpdated Aug 22, 2025

Effect of Cryotherapy Modalities on Skin Temperature, Radial Artery Size and Flow Where Arterial Puncture Are Performed

An interventional study of Crushed ice and Frozen peas in Temperature, Blood Flow Velocity and Radial Artery Size, sponsored by Julio Alberto Mateos Arroyo. Suspended at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Julio Alberto Mateos Arroyo · Not applicable, Interventional, and Supportive care

Why this study was suspended
The study has been postponed indefinitely. It is likely to be carried out in 2026-27
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Low-intervention clinical trial. The thermal and hemodynamic effects of different cryotherapy devices are evaluated. This study is included in the doctoral thesis of the principal investigator.

Investigators:

Principal Investigator: Julio Alberto Mateos Arroyo (RN, MSc, PhD student) Directors: Ignacio Zaragoza García (RN, PhD), Ismael Ortuño Soriano (RN, PhD), Paloma Posada Moreno (PhD).

Setting: Faculty of Nursing, Physiotherapy and Podiatry of the Universidad Complutense de Madrid.

The three interventions to be evaluated are:

  • Applying crushed ice.
  • Apply frozen peas.
  • Apply comparator.

Hypothesis: There are differences in the reduction of temperature, dimensions of the internal lumen of the radial artery and blood flow inside it depending on the different modalities of cryotherapy (crushed ice or bag of frozen peas) applied in the anatomical area of the wrist, point of arterial puncture for blood gas analysis.

Main objective: To analyze the effect of 3 cryotherapy devices on the radial artery area.

Secondary objectives

  • To analyze the thermal behavior of the superficial tissue under study according to the cryotherapy device used.
  • To analyze the differences in the radial artery caliber before and after the application of cold in the different experimental modalities under study.
  • To analyze the differences in radial artery blood flow before and after the application of cold in the different experimental modalities under study.
  • To identify the safety pattern of the use of the different cryotherapy devices (adverse events).

Design: Randomized controlled clinical trial. This is a crossover clinical trial in which all participants will receive all interventions and will be randomized in the order in which they receive them.

Population: Adults with a good general state of health, who specifically do not have factors that could affect their thermoregulation or vascular pathologies.

Main variables:

  • Skin surface temperature.
  • Radial artery size.
  • Radial artery blood flow.
Read the detailed description

Pain caused by arterial puncture for blood gas analysis is one of the most common problems with this procedure. The low utilization rates of effective methods by healthcare providers for pain reduction, such as subcutaneous infiltration of anesthetics, make it necessary to search for effective and simple methods. The use of cryotherapy devices has proven effective for this purpose because the decrease in temperature increases pain threshold and tolerance due to a reduction in nerve conduction velocity and inhibition of nociceptors. In order to standardize these devices, it is necessary to understand the specific thermodynamic and hemodynamic effects of these devices. At the hemodynamic level, the reduction in temperature can produce arterial vasoconstriction. This effect may decrease the palpation of the radial artery, a necessary step for the identification of the optimal point of arterial puncture. Our hypothesis is that there are differences in temperature reduction, radial artery internal lumen dimensions and blood flow inside the radial artery depending on the different cryotherapy modalities applied in the anatomical area of the wrist, the point of arterial puncture for blood gas analysis. In order to obtain an answer to this hypothesis, we will propose a randomized controlled clinical trial with a sham comparator and two active interventions: crushed ice and frozen peas. In addition, this trial has a crossover design with the aim of minimizing the differences that may arise due to individual particularities (within-group variability), and thus increase the possible effect of the interventions (between-group variability). This choice has its justification in that the application of cryotherapy, according to some studies, has a thermal reducing effect with high individual variability. In this study, adults with a good general state of health, who specifically do not have factors that could affect their thermoregulation or vascular pathologies, will be recruited.

02

Conditions studied

  • Temperature
  • Blood Flow Velocity
  • Radial Artery Size

Keywords

  • Cryotherapy
  • Skin temperature
  • Radial artery
  • Hemodynamics
03

In context

Lead sponsor

This is the only study on the registry with Julio Alberto Mateos Arroyo as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Good general health.
  • Conscientious, with full cognitive and communicative capacity.
  • Signed informed consent for this randomized clinical trial.

Exclusion criteria

Exclusion Criteria:

  • Active smoker.
  • Cardiovascular disease.
  • Peripheral vascular disease.
  • Cyanosis of hands and fingers, Raynaud's Syndrome, Scleroderma and/or CREST Syndrome.
  • Diabetes.
  • Surgery, recent wounds or any type of major injury affecting the neck, shoulder girdle, upper limbs and/or hands.
  • Carrier of an arterio-venous fistula.
  • Lack of sensitivity to cold.
  • Alcohol or caffeine intake in the last 24 hours.
  • Intense physical exercise in the last 24 hours.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Order number 1: Ice-Peas-Control

    Each subject will receive all interventions and the control and they will randomly assigned to a sequence order. In this arm the sequence order is: crushed ice - frozen peas - control.

    Device: Crushed ice · Device: Frozen peas · Device: Room temperature gel

  • Experimental
    Order number 2: Ice-Control-Peas

    Each subject will receive all interventions and the control and they will randomly assigned to a sequence order. In this arm the sequence order is: crushed ice - control - frozen peas.

    Device: Crushed ice · Device: Frozen peas · Device: Room temperature gel

  • Experimental
    Order number 3: Peas-Ice-Control

    Each subject will receive all interventions and the control and they will randomly assigned to a sequence order. In this arm the sequence order is: frozen peas - crushed ice - control.

    Device: Crushed ice · Device: Frozen peas · Device: Room temperature gel

  • Experimental
    Order number 4: Peas-Control-Ice

    Each subject will receive all interventions and the control and they will randomly assigned to a sequence order. In this arm the sequence order is: frozen peas - control - crushed ice.

    Device: Crushed ice · Device: Frozen peas · Device: Room temperature gel

  • Experimental
    Order number 5: Control-Ice-Peas

    Each subject will receive all interventions and the control and they will randomly assigned to a sequence order. In this arm the sequence order is: control - crushed ice - frozen peas.

    Device: Crushed ice · Device: Frozen peas · Device: Room temperature gel

  • Experimental
    Order number 6: Control-Peas-Ice

    Each subject will receive all interventions and the control and they will randomly assigned to a sequence order. In this arm the sequence order is: control - frozen peas - crushed ice.

    Device: Crushed ice · Device: Frozen peas · Device: Room temperature gel

Interventions

  • DeviceCrushed ice

    Each participant will receive two active devices and one sham comparator in a crossover design.The cryotherapy device used consists of an opaque bag with a plastic outer cover and an aluminum interior filled with 80 grams of crushed ice. This device is applied on the skin where the optimal palpation point of the radial artery is located, where arterial puncture for blood gas analysis is usually performed to reduce skin temperature in ranges that decrease nerve conduction velocity and increase pain threshold.

    Also known as: ih1

  • DeviceFrozen peas

    Each participant will receive two active devices and one sham comparator in a crossover design. The cryotherapy device used consists of an opaque bag with a plastic outer cover and an aluminum interior filled with 80 grams of frozen peas. This device is applied on the skin where the optimal palpation point of the radial artery is located, where arterial puncture for blood gas analysis is usually performed to reduce skin temperature in ranges that decrease nerve conduction velocity and increase pain threshold.

    Also known as: ig2

  • DeviceRoom temperature gel

    Each participant will receive two active devices and one sham comparator in a crossover design. The sham comparator device used consists of an opaque bag with an external plastic cover and an aluminum interior filled with 80 grams of ultrasound gel at room temperature. This device is applied on the skin where the optimal palpation point of the radial artery is located, where arterial puncture for blood gas analysis is usually performed.

    Also known as: ctrl

06

What researchers measure

Primary outcomes

  1. Skin temperature

    Surface temperature measurements will be taken at different times since the application of the interventions. The thermal camera FLIR TG267 will be used, temperature range: -25ºC to 380ºC, sensitivity \<70ºC mK, resolution 160 X 120.

    Time frame: Prior to application of the intervention

  2. Skin temperature

    Surface temperature measurements will be taken at different times since the application of the interventions. The thermal camera FLIR TG267 will be used, temperature range: -25ºC to 380ºC, sensitivity \<70ºC mK, resolution 160 X 120.

    Time frame: After 5 minutes from the application of the intervention

  3. Skin temperature

    Surface temperature measurements will be taken at different times since the application of the interventions. The thermal camera FLIR TG267 will be used, temperature range: -25ºC to 380ºC, sensitivity \<70ºC mK, resolution 160 X 120.

    Time frame: After 10 minutes from the application of the intervention

  4. Skin temperature

    Surface temperature measurements will be taken at different times since the application of the interventions. The thermal camera FLIR TG267 will be used, temperature range: -25ºC to 380ºC, sensitivity \<70ºC mK, resolution 160 X 120.

    Time frame: After 15 minutes from the application of the intervention

  5. Skin temperature

    Surface temperature measurements will be taken at different times since the application of the interventions. The thermal camera FLIR TG267 will be used, temperature range: -25ºC to 380ºC, sensitivity \<70ºC mK, resolution 160 X 120.

    Time frame: After 20 minutes from the application of the intervention

Secondary outcomes

  1. Change in radial artery size

    Three measurements of the anteroposterior diameter of the radial artery will be taken in the same place and plane to ensure reliability at each time point studied. Samsung HS50 ultrasound scanner with a 3-14 Hz linear probe will be used for the measurement.

    Time frame: 0-20 minutes

  2. Change in radial artery blood flow

    To obtain the blood flow of the radial artery, color Doppler mode will be used to correctly identify the vessel and then the pulsed Doppler mode will be used to obtain the peak systolic low (PSV), that is, the maximum systolic velocity (VSM). Three consecutive PSV measurements will be obtained in the same place and plane to ensure reliability at each time point studied. Samsung HS50 ultrasound scanner with a 3-14 Hz linear probe will be used for the measurement.

    Time frame: 0-20 minutes

Other outcomes

  1. Discomfort

    The discomfort generated by the interventions and the comparator will be recorded 5, 10, 15 and 20 minutes after their application. An ad hoc likert-type numerical scale will be used, where 1 means no discomfort and 10 means extreme discomfort.

    Time frame: After 5 minutes from the application of the intervention

  2. Discomfort

    The discomfort generated by the interventions and the comparator will be recorded 5, 10, 15 and 20 minutes after their application. An ad hoc likert-type numerical scale will be used, where 1 means no discomfort and 10 means extreme discomfort.

    Time frame: After 10 minutes from the application of the intervention

  3. Discomfort

    The discomfort generated by the interventions and the comparator will be recorded 5, 10, 15 and 20 minutes after their application. An ad hoc likert-type numerical scale will be used, where 1 means no discomfort and 10 means extreme discomfort.

    Time frame: After 15 minutes from the application of the intervention

  4. Discomfort

    The discomfort generated by the interventions and the comparator will be recorded 5, 10, 15 and 20 minutes after their application. An ad hoc likert-type numerical scale will be used, where 1 means no discomfort and 10 means extreme discomfort.

    Time frame: After 20 minutes from the application of the intervention

  5. Adverse events

    Number of participants with adverse events

    Time frame: Through study completion, an average of 3 months

07

Study locations

1 site
  • Gerencia de Atención Integrada de Talavera de la Reina
    Talavera de la Reina, Toledo 45600, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05915234
Lead sponsor
Julio Alberto Mateos Arroyo
Collaborators
Universidad Complutense de Madrid, Hospital General Nuestra Señora del Prado
Responsible party
Julio Alberto Mateos Arroyo (Principal Investigator, Hospital General Nuestra Señora del Prado) — Sponsor-investigator
First posted
Jun 22, 2023
Start date
Dec 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Aug 22, 2025

Study contacts

Ignacio Zaragoza García, RN, PhD
study director · Universidad Complutense de Madrid
Ismael Ortuño Soriano, RN, PhD
study director · Universidad Complutense de Madrid
Paloma Posada Moreno, PhD
study director · Universidad Complutense de Madrid

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion